Actions of dopaminergic agonists on motor function.
D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001519:Behavior / Q000187:drug effects*; D003913:Dextroamphetamine / Q000494:pharmacology; D004195:Disease Models, Animal; D018492:Dopamine Antagonists; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D007980:Levodopa / Q000494:pharmacology; D008774:Methylphenidate / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000139:chemically induced*; D010627:Phenethylamines / Q000494:pharmacology; D010891:Piribedil / Q000031:analogs & derivatives; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects*; D014443:Tyrosine / Q000031:analogs & derivatives / Q000494:pharmacology
D018492:Dopamine Antagonists; D010627:Phenethylamines; D008774:Methylphenidate; D014443:Tyrosine; D007980:Levodopa; D000547:Amantadine; D010891:Piribedil; D001058:Apomorphine; D003913:Dextroamphetamine